Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |